Healthcare - Medika Life

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life - August 6, 2020

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

Medika Life - December 22, 2020

Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics

HIMSS – Global Meeting Ground for Health Info Innovators to Secure Partnerships and Advance Care

Gil Bashe, Medika Life Editor - March 4, 2024

10 Israeli Innovators Head Toward Orlando with New Approaches to Hospital Efficiency and Improved Patient Care - Showing Engineering Marvel and AI Potential

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

The Stroke That Stole My Father And the Tiny Device That Could Stop the Next One

“Humility” Is Cutting-Edge Medicine: What a Physician Innovator Teaches Us About Patient-Centered Care

Beans Are Now the Super Food That We All Need, So Get Ready for a New Diet

Nurse Practitioners Critical in Treating Older Adults as Ranks of Geriatricians Shrink

LATEST

TRENDING

Video of Jordon Walker, Supposed Pfizer Researcher, Goes Viral

Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

Is Your Covid Test Being Used to Covertly Harvest Your DNA?

The Medika Life Top 30 Voices Transforming Wellness for 2022/23

Medika’s Top 20 AI Voices to Watch. Follow These Experts as They Demystify AI and Its Future

The Medika Life 50 – The Most Influential Voices in Health for 2022

Women Transforming Healthcare: The Medika Life 2022 Top 30

Is the Covid Vaccine’s Spike Protein Killing Us?

Fifty of the Most Influential Voices in Healthcare for 2021

I want one! Six of The Coolest New Medical Gadgets on the Market

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

HIMSS – Global Meeting Ground for Health Info Innovators to Secure Partnerships and Advance Care

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories